Lymphatic Filariasis (Elephantiasis) Elimination: A public health success and development opportunity

Filaria Journal

Volumn 2, Issue , 2003, Pages

  Molyneux, David ^a  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; AZITHROMYCIN; DIETHYLCARBAMAZINE; IVERMECTIN; RETINOL;

ARTICLE; ASIAN; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST; ELEPHANTIASIS; FEASIBILITY STUDY; FILARIASIS; HEALTH CARE SYSTEM; HEALTH PROGRAM; HUMAN; LYMPHATIC SYSTEM DISEASE; MEDICAL DOCUMENTATION; MEDICAL RESEARCH; PHYSICAL DISABILITY; POVERTY; PUBLIC HEALTH SERVICE; SRI LANKA; TREATMENT PLANNING; WORLD HEALTH ORGANIZATION;

EID: 2942517750     PISSN: 14752883     EISSN: None     Source Type: Journal    
DOI: 10.1186/1475-2883-2-13     Document Type: Article

References (16)

1. Recommendations of the International Task Force for Disease Eradication. MMWR Recomm Rep 1993, 42:1-38.
2. Ismail MM, Jayakody RL, Weil GJ, Nirmalan N, Jayasinghe KS, Abeyewickrema W, Rezvi Sheriff MH, Rajaratnam HN, Amarasekera N, de Silva DC, Michalski ML and Dissanaike AS: Efficacy of single dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis. Trans R Soc Trop Med Hyg 1998, 92:94-97.
3. Weil GJ, Lammie PJ and Weiss N: The ICT Filariasis Test: A Rapid-format Antigen Test for Diagnosis of Bancroftian Filariasis. Parasitol Today 1997, 13:401-404.
4. Amaral F, Dreyer G, Figueredo-Silva J, Noroes J, Cavalcanti A, Samico SC, Santos A and Coutinho A: Live adult worms detected by ultrasonography in human Bancroftian filariasis. Am J Trop Med Hyg 1994, 50:753-757.
5. Mand S, Marfo-Debrekyei Y, Dittrich M, Fischer K, Adjei O and Hoerauf A: Animated documentation of the filaria dance sign (FDS) in bancroftian filariasis. Filaria J 2003, 2:3.
6. Dreyer G, Addiss D, Dreyer P and Norões J: Basic Lymphoedema Management. Treatment and prevention of problems associated with lymphatic filariasis. 1st edition. New Hampshire, Hollis; 2002:112.
7. Molyneux DH, Neira M, Liese B and Heymann D: Lymphatic filariasis: setting the scene for elimination. Trans R Soc Trop Med Hyg 2000, 94:589-591.
8. Ottesen EA, Duke BO, Karam M and Behbehani K: Strategies and tools for the control/elimination of lymphatic filariasis. Bull World Health Organ 1997, 75:491-503.
9. Molyneux DH and Zagaria N: Lymphatic filariasis elimination: progress in global programme development. Ann Trop Med Parasitol 2002, 96 Suppl 2:S15-40.
10. Brown MJ, Njongmeta LH, Addiss D, Ngwira B, Fiack C, Ottesen EA, Bassanez M and Molyneux DH: Review of historical data of lymphatic filariasis control programmes - Evidence that lymphatic filariasis can be eliminated as a public health problem. Filaria J 2003, In press:.
11. Lymphatic filariasis. Wkly Epidemiol Rec 2003, 78:171-179.
12. Witt C and Ottesen EA: Lymphatic filariasis: an infection of childhood. Trop Med Int Health 2001, 6:582-606.
13. Lammie PJ, Reiss MD, Dimock KA, Streit TG, Roberts JM and Eberhard ML: Longitudinal analysis of the development of filarial infection and antifilarial immunity in a cohort of Haitian children. Am J Trop Med Hyg 1998, 59:217-221.
14. Bockarie MJ, Tisch DJ, Kastens W, Alexander ND, Dimber Z, Bockarie F, Ibam E, Alpers MP and Kazura JW: Mass treatment to eliminate filariasis in Papua New Guinea. N Engl J Med 2002, 347:1841-1848.
15. Addiss DG: Mass treatment of filariasis in New Guinea. N Engl J Med 2003, 348:1179-81; author reply 1179-81.
16. Galvez Tan JZ: The Elimination of Lymphatic Filariasis: A Strategy for Poverty Alleviation and Sustainable Development - Perspectives from the Philippines. Filaria J 2003, 2:12.